Crescendus

TYPES OF DATA MONITORED (can be customized by your specific need)

 

• USA Competitor Strategy

• Clinical Pipeline (Products in Development)

• Mechanism of Action

• Alliances & Partnering Activities

• Acquisitions

• Divestitures

• Litigations

• Licensing

• Product Launch Timelines (incl. Delays, if any)

• Strategic R&D Initiatives

• Management Strategy Updates

• Sales of Key Products (if Public)

• Strategic Commentary on Market & Industry Conditions/Hurdles

• Patent Filings

• Regulatory Violations

 

 

 

THERAPEUTIC AREAS

 

• Oncology

• Cardiovascular

• Metabolic

• Neuroscience

• Immune System

• Inflammation

• Rare Disease

• Vaccines

• Respiratory

• Infectious

• Womens Health

• Gastrointestinal

• Opthalmology

 

 

 

DATA SOURCES

 

All data is monitored from publicly available sources within the US market and is updated frequently (as opposed to static market research reports).

 

 

 

DELIVERABLES

 

MS Excel Data file, that is updated monthly. Weekly updates are also available (additional fees apply). Actual entries in Spreadsheet will vary by month. Only recent competitor data updates will be monitored. If there are no changes or new developments, then those columns will be left blank for the given month.

 

Other formats (e.g. Powerpoints for your internal R&D, Product or Strategy sessions), PDFs & Word Documents are also available based on client's specific needs.

 

 

 

PRICING & PAYMENTS

 

Our pricing varies by data sources, extent of customization, frequency of delivery, reporting formats and number of client users. Contact us to discuss your specific needs. Currently, we only accept payments via PayPal (payment required prior to deliverables). Additional terms & conditions apply, which will be disclosed during client discussions.

 

 

 

TARGET AUDIENCE

 

The Competitive Intelligence information will be useful for the following target audience within Pharma, Biotech, Generics and Supply Chain companies and their investors (e.g. Venture Capital, Private Equity, Institutional Investors etc.):

 

• VP Marketing & Products

• VP Strategy & Innovation

• CEO, CFO & Board of Directors

• VP Corporate & Business Development

• VP Legal

• VP Sales & Services

• VP R&D & Engineering

• VP Reguatory & Quality Assurance

• Heads of Diseases/Business Units

• VP Operations & Manufacturing

• VP Supply Chain

• Directors of Strategy, Marketing, Sales, Product Development, Operations, Regulatory & Quality

• Product Managers

• Sales & Marketing Managers

• Principal Scientists (R&D, by Disease)

• Financial Controllers

• Subject Matter Experts (e.g. Clinical, Engineers, Scientists)

• Business Development Managers

 

 

The impact of this vital Competitive Intelligence data will be felt across all critical business functions (e.g. Product Development, Portfolio Management, Marketing, Sales, Resource Allocations, Business Development, Strategy & Scenario Planning, etc.).